We want to identify really useful peptides that can be leveraged and advanced as treatment for human diseases for which there is no solution at the moment. One potential prospect is MOTs-C, which Cohen discovered and has studied in Phase 1A and Phase 1B trials
Uncommon (110 in 1,000 people): muscle cramps, restlessness, increased heart rate, dizziness
Why GLP-1 Support Is Not The Same As GLP-1 Medication Supporting metabolic health through nutrition is not the same as altering hormone signaling
The American Journal of Sports Medicine A systematic review of 35 preclinical studies on BPC-157 in musculoskeletal models was published in 2026
Fatigue is common initially as your body adjusts to fewer calories and changing blood sugar levels, and you should also monitor for any vision changes that may occur
This approach isnt designed for people with diabetes, who are more likely to need medication for the long term